Blood test to check for cancer risk before ovarian mass surgery
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a new blood test to help doctors determine if an ovarian mass is cancerous before surgery. If you are a woman over 18 with an ovarian cyst or mass that needs surgery, this test could help guide your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have an ovarian cyst or mass that has been seen on an ultrasound and needs surgery, but you have not had that surgery yet.
- You have not had ovarian cancer before or been treated for it.
- You have not had both ovaries removed in a past surgery.
- You have not had any gynecologic cancer or melanoma in the last 2 years.
- You are not pregnant or breastfeeding, and have not had chemotherapy, radiation, or immunotherapy in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects a blood sample before you have surgery or a biopsy for an ovarian mass. Researchers will test whether a new blood test can accurately identify ovarian cancer by looking at DNA patterns in your blood. The results will help doctors understand if this blood test could help detect ovarian cancer earlier in the future.
This study checks whether a special blood test (circulating tumor DNA) can help find ovarian cancer when it’s suspected. It may help doctors diagnose more accurately and sooner, so the right treatment can start sooner.
This study looks for early signs of ovarian cancer in a simple blood test. It may help people with BRCA gene changes catch problems sooner, before or after preventive surgery.
This study is for women with advanced ovarian cancer who have finished first treatment and are in complete remission. It uses a blood test to look for tiny amounts of leftover cancer cells, which could help guide future care.
This trial looks at tiny molecules in the blood to help diagnose ovarian germ cell tumors. It compares results from people with malignant (cancerous) tumors, benign (non-cancerous) tumors, and those without any gynecologic condition.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.